Your session is about to expire
← Back to Search
R-5280 (HAMS-AB) for Type 1 Diabetes (R-5280 Trial)
R-5280 Trial Summary
This trial studies how well HAMS-AB helps people with newly diagnosed Type 1 Diabetes manage their condition.
R-5280 Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowR-5280 Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.R-5280 Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What qualifications must individuals meet to partake in this research?
"The requirements to enroll in this clinical study are a diagnosis of Type 1 diabetes and an age between 11-17. Currently, 39 participants are needed for the trial."
Does this trial accommodate those of advanced age?
"According to the eligibility requirements, patients must be between 11 and 17 years of age. In total, there are 219 clinical trials involving minors and 958 for senior citizens."
What is the current standing of Active Comparator with regards to FDA approval?
"Although there is limited evidence of safety or efficacy, the risk associated with Active Comparator was evaluated as a 1."
Are there still slots available for prospective participants of this trial?
"Clinicaltrials.gov provides evidence that this trial is not currently recruiting patients, despite first being posted on November 1st 2023 and last edited on September 21st 2023. Though no further volunteers are needed for this particular study, there are 1297 other clinical trials actively seeking participants at the moment."
Share this study with friends
Copy Link
Messenger